Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00483028 · ClinicalTrials.gov registry record · NA
A Randomized, Placebo-Controlled Trial to Examine the Efficacy of Oral Donepezil in Subjects With MCI
A NA study, sponsored by Pfizer.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT00483028 is a NA study that has completed, run by Pfizer. The registered enrollment target is 38 participants.
The verdict
NCT00483028, a NA study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
To purpose of this study is to estimate the effect of donepezil on Neuropsychological Testing (NPT) and brain Proton Magnetic Resonance Spectroscopy.
Interventions
- DRUG donezepil (Aricept)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2004-06 |
| Est. Completion | 2007-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00483028
The ClinicalTrials.gov registry entry for NCT00483028 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which donezepil (Aricept) is the first listed.
NCT00483028 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00483028 about?
NCT00483028 is a clinical study titled "A Randomized, Placebo-Controlled Trial to Examine the Efficacy of Oral Donepezil in Subjects With MCI". To purpose of this study is to estimate the effect of donepezil on Neuropsychological Testing (NPT) and brain Proton Magnetic Resonance Spectroscopy.
What is the current status of trial NCT00483028?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2004-06. Estimated completion is 2007-01.
What interventions are being tested in trial NCT00483028?
The interventions under investigation include: donezepil (Aricept) (DRUG).
Who is sponsoring clinical trial NCT00483028?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.